Citius Pharmaceuticals, Inc. (CTXR) Operating cash flow 2016–2025
Citius Pharmaceuticals, Inc. (CTXR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$26.6MFY2025 · since FY2016: -$5.9M → -$26.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.6M | +5.8% |
| FY2024 | -$28.2M | +3.0% |
| FY2023 | -$29.1M | -2.5% |
| FY2022 | -$28.4M | -17.0% |
| FY2021 | -$24.3M | -43.2% |
| FY2020 | -$16.9M | -36.1% |
| FY2019 | -$12.4M | -9.9% |
| FY2018 | -$11.3M | -42.0% |
| FY2017 | -$8.0M | -35.1% |
| FY2016 | -$5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR RevenueCTXR Net incomeCTXR Net marginCTXR Gross profitCTXR Gross marginCTXR Operating incomeCTXR Operating marginCTXR Free cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total assetsCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →